Suggestions
John Lambert
Chief Executive Officer at Amplia Therapeutics Limited
Dr. John Lambert is a seasoned professional in the field of drug development, who served as the Chief Executive Officer (CEO) and Managing Director of Amplia Therapeutics Limited from June 2019 to November 2022.
Background and Education
Dr. Lambert holds a PhD in organic chemistry and has a post-doctoral background in bioorganic chemistry. He began his career in academia, working as a lecturer at the University of Melbourne in the mid-1990s, where he recognized the value of industry collaboration.2
Career
- Biota Pharmaceuticals: Dr. Lambert joined Biota Pharmaceuticals in 2001 as the Head of Chemistry and spent 14 years in various drug development and senior management roles. When Biota relocated its operations to the USA, he moved to Medicines Development for Global Health (MDGH), a not-for-profit biopharmaceutical company dedicated to developing affordable medicines and vaccines.2
- Medicines Development for Global Health: At MDGH, he continued his work in drug development while also doing consulting work.
- Amplia Therapeutics: Dr. Lambert joined Amplia Therapeutics in August 2018 as Operations Manager. He was appointed as the CEO on June 24, 2019, and later became the Managing Director on February 6, 2020. During his tenure, he was instrumental in advancing the company's pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis, particularly focusing on pancreatic and ovarian cancer, as well as idiopathic pulmonary fibrosis.126
Experience and Expertise
Dr. Lambert has over 20 years of experience in the full drug development lifecycle, including early discovery, intellectual property protection, licensing, product development, and regulatory approval. He is known for his ability to assemble and lead high-performing, multidisciplinary teams and for his commitment to advancing treatments for underserved medical needs.126
Resignation
Dr. Lambert resigned from his position as CEO and Managing Director of Amplia Therapeutics in September 2022, with his departure effective in November 2022.45
Current Role
After leaving Amplia Therapeutics, Dr. Lambert is currently associated with Atticus Medical, where he serves as the General Manager.3
